Clinical Trial Update: Chewed Versus Integral Pill of Ticagrelor [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing chewed versus intact ticagrelor tablets in patients undergoing percutaneous coronary intervention; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Brilinta (ticagrelor) (ticagrelor)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED | Results posted: 2023-01-18